These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20712798)

  • 1. Redefining thalassemia as a hypercoagulable state.
    Cappellini MD; Motta I; Musallam KM; Taher AT
    Ann N Y Acad Sci; 2010 Aug; 1202():231-6. PubMed ID: 20712798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalassemia and hypercoagulability.
    Taher AT; Otrock ZK; Uthman I; Cappellini MD
    Blood Rev; 2008 Sep; 22(5):283-92. PubMed ID: 18511163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypercoagulable state in thalassemia intermedia.
    Taher AT; Musallam KM; Inati A
    Hemoglobin; 2009; 33 Suppl 1():S160-9. PubMed ID: 20001621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombosis in thalassemia: why are we so concerned?
    Musallam KM; Taher AT
    Hemoglobin; 2011; 35(5-6):503-10. PubMed ID: 21910599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercoagulability in β-thalassemia: a status quo.
    Cappellini MD; Poggiali E; Taher AT; Musallam KM
    Expert Rev Hematol; 2012 Oct; 5(5):505-11; quiz 512. PubMed ID: 23146054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation and splenectomy: an overview.
    Cappellini MD; Grespi E; Cassinerio E; Bignamini D; Fiorelli G
    Ann N Y Acad Sci; 2005; 1054():317-24. PubMed ID: 16339680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulopathy in Beta-thalassemia: current understanding and future perspectives.
    Cappellini MD; Musallam KM; Marcon A; Taher AT
    Mediterr J Hematol Infect Dis; 2009 Dec; 1(1):e2009029. PubMed ID: 21415997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intermediate thalassemia: a new condition associated with hypercoagulability].
    Mannucci PM
    Ann Ital Med Int; 2000; 15(3):187-8. PubMed ID: 11059057
    [No Abstract]   [Full Text] [Related]  

  • 9. [Advances in pathogenesis and correlated clinical research of hypercoagulability in β thalassemia].
    Lv RY; Wen FQ; Yu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):774-8. PubMed ID: 25008893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercoagulability and Vascular Disease.
    Taher AT; Cappellini MD; Bou-Fakhredin R; Coriu D; Musallam KM
    Hematol Oncol Clin North Am; 2018 Apr; 32(2):237-245. PubMed ID: 29458729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia.
    Cappellini MD; Robbiolo L; Bottasso BM; Coppola R; Fiorelli G; Mannucci AP
    Br J Haematol; 2000 Nov; 111(2):467-73. PubMed ID: 11122086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalassemia and venous thromboembolism.
    Succar J; Musallam KM; Taher AT
    Mediterr J Hematol Infect Dis; 2011; 3(1):e2011025. PubMed ID: 21713079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypercoagulable state in thalassemia.
    Eldor A; Rachmilewitz EA
    Blood; 2002 Jan; 99(1):36-43. PubMed ID: 11756150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of pulmonary thromboembolism in thalassemia intermedia: are these patients at risk for thrombotic events?
    Ciceri L; Amato M; Cappellini MD; Fiorelli G
    Ann Ital Med Int; 2000; 15(3):218-20. PubMed ID: 11059063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal vein thrombosis after splenectomy for beta-thalassemia major.
    Al-Hawsawi ZM; Haouimi AS; Hassan RA; Tarawah AM
    Saudi Med J; 2004 Feb; 25(2):225-8. PubMed ID: 14968225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse model to study thrombotic complications of thalassemia.
    Kalish Y; Malyutin Z; Shai E; Dana M; Avraham L; Jahshan N; Rachmilewitz E; Fibach E; Varon D
    Thromb Res; 2015 Mar; 135(3):521-5. PubMed ID: 25613926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalassemia intermedia: revisited.
    Taher A; Isma'eel H; Cappellini MD
    Blood Cells Mol Dis; 2006; 37(1):12-20. PubMed ID: 16737833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercoagulability in non-transfusion-dependent thalassemia.
    Cappellini MD; Musallam KM; Poggiali E; Taher AT
    Blood Rev; 2012 Apr; 26 Suppl 1():S20-3. PubMed ID: 22631037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients.
    Kashuk JL; Moore EE; Sabel A; Barnett C; Haenel J; Le T; Pezold M; Lawrence J; Biffl WL; Cothren CC; Johnson JL
    Surgery; 2009 Oct; 146(4):764-72; discussion 772-4. PubMed ID: 19789037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Thromboelastogram in monitoring the activation of the coagulation pathway and assessing the associated risk factors for hypercoagulable state in transfusion dependent thalassemia patients.
    Shastry S; Mohan G; Pa P; Mundkur S; Kurien A; Ahammad J
    Transfus Apher Sci; 2023 Apr; 62(2):103583. PubMed ID: 36344327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.